{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:07:57Z","timestamp":1790611677759,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.lfs.2022.120590","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T10:53:21Z","timestamp":1651316001000},"page":"120590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Trimetazidine attenuates cyclophosphamide-induced cystitis by inhibiting TLR4-mediated NF\u03baB signaling in mice"],"prefix":"10.1016","volume":"301","author":[{"given":"Se\u00e7kin","family":"Engin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Nur","family":"Barut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye\u015fim Kaya","family":"Ya\u015far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysun \u00c7elik","family":"Soysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu\u011fba","family":"Ar\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6k\u00e7en","family":"Kerimo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Kad\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sena F.","family":"Sezen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lfs.2022.120590_bb0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","article-title":"The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy","volume":"78","author":"Ahlmann","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120590_bb0010","first-page":"199","article-title":"Mechanisms of hemorrhagic cystitis","volume":"2","author":"Haldar","year":"2014","journal-title":"Am. J. Clin. Exp. Urol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120590_bb0015","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00003495-199142050-00005","article-title":"Cyclophosphamide toxicity. Characterising and avoiding the problem","volume":"42","author":"Fraiser","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2022.120590_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117901","article-title":"Ameliorate effect of pyrroloquinoline quinone against cyclophosphamide-induced nephrotoxicity by activating the Nrf2 pathway and inhibiting the NLRP3 pathway","volume":"256","author":"Lin","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2022.120590_bb0025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5604\/17322693.1009703","article-title":"Bladder urotoxicity pathophysiology induced by the oxazaphosphorine alkylating agents and its chemoprevention","volume":"66","author":"Dobrek","year":"2012","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"issue":"10","key":"10.1016\/j.lfs.2022.120590_bb0030","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1065-6995(03)00175-6","article-title":"Immunohistochemical detection of apoptosis, proliferation and inducible nitric oxide synthase in rat urothelium damaged by cyclophosphamide treatment","volume":"27","author":"Jezernik","year":"2003","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.lfs.2022.120590_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.urology.2016.07.030","article-title":"Review of advances in uroprotective agents for cyclophosphamide- and ifosfamide-induced hemorrhagic cystitis","volume":"100","author":"Matz","year":"2017","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.lfs.2022.120590_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/pbc.20617","article-title":"Adverse hypersensitivity reactions to mesna as adjunctive therapy for cyclophosphamide","volume":"49","author":"Khaw","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2022.120590_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12818","article-title":"Toll-like receptors: the role in bladder cancer development, progression and immunotherapy","volume":"90","author":"Ohadian Moghadam","year":"2019","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.lfs.2022.120590_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116704","article-title":"The role of toll-like receptors in the protective effect of melatonin against doxorubicin-induced pancreatic beta cell toxicity","volume":"233","author":"Taskin","year":"2019","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.lfs.2022.120590_bb0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2022.120590_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172975","article-title":"Toll-like receptor 4: a promising crossroads in the diagnosis and treatment of several pathologies","volume":"874","author":"Garcia","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120590_bb0065","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00100.2018","article-title":"Deletion or pharmacological blockade of TLR4 confers protection against cyclophosphamide-induced mouse cystitis","volume":"315","author":"de Oliveira","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120590_bb0070","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00017.2019","article-title":"Cystitis-induced bladder pain is toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP research network animal study","volume":"317","author":"Cui","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120590_bb0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1527-3466.2008.00043.x","article-title":"Trimetazidine revisited: a comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine","volume":"26","author":"Onay-Besikci","year":"2008","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.lfs.2022.120590_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2017.02.083","article-title":"Trimetazidine in conditions other than coronary disease, old drug, new tricks?","volume":"234","author":"Zou","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.lfs.2022.120590_bb0085","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3109\/0886022X.2014.949765","article-title":"Effects of trimetazidine on the Akt\/eNOS signaling pathway and oxidative stress in an in vivo rat model of renal ischemia-reperfusion","volume":"36","author":"Mahfoudh-Boussaid","year":"2014","journal-title":"Ren. Fail."},{"issue":"3","key":"10.1016\/j.lfs.2022.120590_bb0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.metabol.2015.10.022","article-title":"The protective effect of trimetazidine on myocardial ischemia\/reperfusion injury through activating AMPK and ERK signaling pathway","volume":"65","author":"Liu","year":"2016","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.lfs.2022.120590_bb0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fphar.2019.00175","article-title":"Trimetazidine attenuates exhaustive exercise-induced myocardial injury in rats via regulation of the Nrf2\/NF-\u03baB signaling pathway","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120590_bb0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000088211","article-title":"Pharmacological investigation of trimetazidine in models of inflammation, pain and gastric injury in rodents","volume":"75","author":"Abdel-Salam","year":"2005","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.lfs.2022.120590_bb0105","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/bph.13386","article-title":"Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1","volume":"173","author":"Chen","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120590_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e05948","article-title":"Drug combination and repurposing for cancer therapy: the example of breast cancer","volume":"7","author":"Correia","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.lfs.2022.120590_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2407-13-63","article-title":"Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines","volume":"13","author":"Gest","year":"2013","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2022.120590_bb0120","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3906\/sag-1505-102","article-title":"Effectiveness of a single versus repeated administration of trimetazidine in the protection against warm ischemia\/reperfusion injury of rat liver","volume":"46","author":"Mahfoudh Boussaid","year":"2016","journal-title":"Turk. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2022.120590_bb0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10517-017-3677-2","article-title":"Anxiolytic properties of trimetazidine in experimental models of increased anxiety","volume":"162","author":"Kolik","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"issue":"5","key":"10.1016\/j.lfs.2022.120590_bb0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11255-019-02128-y","article-title":"Uroprotective effect of ambroxol in cyclophosphamide-induced cystitis in mice","volume":"51","author":"Barut","year":"2019","journal-title":"Int. Urol. Nephrol."},{"issue":"11","key":"10.1016\/j.lfs.2022.120590_bb0135","first-page":"4273","article-title":"Uroprotective effect of pantoprazole against cyclophosphamide-induced cystitis in mice","volume":"27","author":"Engin","year":"2019","journal-title":"Support. Care Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2022.120590_bb0140","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00210-021-02055-9","article-title":"Double benefit of metformin treatment: improved bladder function in cyclophosphamide-induced cystitis and enhanced cytotoxicity in cancer cells","volume":"394","author":"Engin","year":"2021","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120590_bb0145","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.juro.2014.12.092","article-title":"Inhibition of NMDAR reduces bladder hypertrophy and improves bladder function in cyclophosphamide induced cystitis","volume":"193","author":"Liu","year":"2015","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.lfs.2022.120590_bb0150","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12012-021-09647-0","article-title":"Improved endothelium-eependent relaxation of thoracic aorta in niclosamide-treated diabetic rats","volume":"21","author":"Engin","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120590_bb0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10787-010-0055-3","article-title":"Protective role of Ipomoea obscura (L.) on cyclophosphamide-induced uro- and nephrotoxicities by modulating antioxidant status and pro-inflammatory cytokine levels","volume":"19","author":"Hamsa","year":"2011","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.lfs.2022.120590_bb0160","first-page":"333","article-title":"Uroprotective mechanisms of natural products against cyclophosphamide-induced urinary bladder toxicity: a comprehensive review","volume":"19","author":"Sherif","year":"2020","journal-title":"Acta Sci. Pol. Technol. Aliment."},{"issue":"3","key":"10.1016\/j.lfs.2022.120590_bb0165","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1097\/MJT.0000000000000180","article-title":"Trimetazidine in practice: review of the clinical and experimental evidence","volume":"23","author":"D\u00e9zsi","year":"2016","journal-title":"Am. J. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2022.120590_bb0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/jpp\/rgab072","article-title":"The inhibitory effect of trimetazidine on detrusor contractility - a potential repositioning of trimetazidine for the treatment of overactive bladder","volume":"74","author":"Engin","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120590_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8424872","article-title":"C-phycocyanin alleviates bladder inflammation and dysfunction in cyclophosphamide-induced cystitis in a mouse model by inhibiting COX-2 and EP4","volume":"2019","author":"Bao","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"44","key":"10.1016\/j.lfs.2022.120590_bb0180","doi-asserted-by":"crossref","first-page":"19084","DOI":"10.1073\/pnas.1005333107","article-title":"Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis","volume":"107","author":"Everaerts","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2022.120590_bb0185","doi-asserted-by":"crossref","first-page":"F85","DOI":"10.1152\/ajprenal.00041.2016","article-title":"Activation of soluble guanylyl cyclase by BAY 58\u20132667 improves bladder function in cyclophosphamide-induced cystitis in mice","volume":"311","author":"de Oliveira","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"12","key":"10.1016\/j.lfs.2022.120590_bb0190","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s11255-014-0833-8","article-title":"Prevention of cyclophosphamide-induced hemorrhagic cystitis by resveratrol: a comparative experimental study with mesna","volume":"46","author":"Keles","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.lfs.2022.120590_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118913","article-title":"Downregulation of redox imbalance and iNOS\/NF-\u0138B\/caspase-3 signalling with zinc supplementation prevents urotoxicity of cyclophosphamide-induced hemorrhagic cystitis in rats","volume":"266","author":"Famurewa","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2022.120590_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173321","article-title":"The effect of O-1602, a GPR55 agonist, on the cyclophosphamide-induced rat hemorrhagic cystitis","volume":"882","author":"Wr\u00f3bel","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120590_bb0205","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/tox.23120","article-title":"Trimetazidine improved adriamycin-induced cardiomyopathy by downregulating TNF-\u03b1, BAX, and VEGF immunoexpression via an antioxidant mechanism","volume":"36","author":"Eid","year":"2021","journal-title":"Environ. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120590_bb0210","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00210-011-0606-1","article-title":"Anticonvulsant and antioxidant actions of trimetazidine in pentylenetetrazole-induced kindling model in mice","volume":"383","author":"Jain","year":"2011","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120590_bb0215","first-page":"124","article-title":"Appreciation of trimetazidine treatment in experimental sepsis rat model","volume":"116","author":"Tanoglu","year":"2015","journal-title":"Bratisl. Lek. Listy"},{"issue":"4","key":"10.1016\/j.lfs.2022.120590_bb0220","first-page":"404","article-title":"The role of toll-like receptors (TLRs) in urinary tract infections (UTIs)","volume":"69","author":"Behzadi","year":"2016","journal-title":"Cent. Eur. J. Urol."},{"issue":"12","key":"10.1016\/j.lfs.2022.120590_bb0225","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.2337\/db16-0480","article-title":"Toll-like receptor 4 activation contributes to diabetic bladder dysfunction in a murine model of type 1 diabetes","volume":"65","author":"Szasz","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2022.120590_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6632359","article-title":"Expression of toll-like receptors in the animal model of bladder outlet obstruction","volume":"2020","author":"Niemczyk","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2022.120590_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117590","article-title":"Chlorogenic acid attenuates cyclophosphamide-induced rat interstitial cystitis","volume":"254","author":"Luo","year":"2020","journal-title":"Life Sci."},{"issue":"18","key":"10.1016\/j.lfs.2022.120590_bb0240","doi-asserted-by":"crossref","first-page":"10677","DOI":"10.1111\/jcmm.15688","article-title":"Danshen (Salvia miltiorrhiza) restricts MD2\/TLR4-MyD88 complex formation and signalling in acute myocardial infarction-induced heart failure","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120590_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2011.09.049","article-title":"Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis\/painful bladder syndrome","volume":"79","author":"Shie","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.lfs.2022.120590_bb0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.intimp.2017.11.010","article-title":"Cytoprotective effects of glycyrrhetinic acid liposome against cyclophosphamide-induced cystitis through inhibiting inflammatory stress","volume":"54","author":"Ge","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120590_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101632","article-title":"Trimetazidine alone or in combination with gemcitabine and\/or abraxane decreased cell viability, migration and ATP levels and induced apoptosis of human pancreatic cells","volume":"45","author":"Atl\u0131 \u015eekero\u011flu","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120590_bb0260","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/13880209.2019.1657905","article-title":"Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK\/mTOR\/autophagy pathway","volume":"57","author":"Yang","year":"2019","journal-title":"Pharm. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120590_bb0265","first-page":"232","article-title":"Protective effects of trimetazidine and coenzyme Q10 on cisplatin-induced cardiotoxicity by alleviating oxidative stress and mitochondrial dysfunction","volume":"22","author":"Zhao","year":"2019","journal-title":"Anatol. J. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120590_bb0270","first-page":"304","article-title":"Protective effects of trimetazidine against doxorubicin-induced cardiotoxicity and hepatotoxicity in mice","volume":"32","author":"Sikandar","year":"2020","journal-title":"J. Ayub Med. Coll. Abbottabad"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522002909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522002909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:59:40Z","timestamp":1758401980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522002909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":54,"alternative-id":["S0024320522002909"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120590","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trimetazidine attenuates cyclophosphamide-induced cystitis by inhibiting TLR4-mediated NF\u03baB signaling in mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120590"}}